United Therapeutics CEO Rothblatt Offloads $5.2 Million in Shares Under Pre-Arranged Plan
Martine A. Rothblatt, Chairperson and CEO of United Therapeutics Corp. (NASDAQ:UTHR), executed a sale of approximately $5.2 million worth of company stock on July 6, 2026. The transactions were carried out through the exercise of stock options and subsequent sales under a pre-arranged trading plan adopted in November 2025. This activity follows a s…